Dr | Group Leader | Coordinator of Cancer Program+61 7 3845 3538
Dr Nic Waddell obtained her PhD in molecular biology from the University of Leicester in the UK. She is head of the Medical Genomics group at QIMR Berghofer Medical Research Institute. Prior to that she has been a post-doctoral researcher at the University of Queensland and QIMR Berghofer. She is a cancer researcher and collaborative bioinformatician who is an expert in the interpretation of next generation sequence data. She has also played a key role in the Australian International Cancer Genome Consortia (ICGC) projects (PIs Grimmond, Biankin and Bowtell) and the Australian Melanoma Genome Project (AMGP).
Her team focuses on the genomics of several cancers including oesophageal, melanoma, mesothelioma and lung cancer. She has received over 10 million AUD of funding as a CI. With an H-index of over 45, she has consistently published in high impact journals including multiple articles in Nature. She is co-founder of precision analytics company, genomiQa. This company specialises in in whole genome data analysis. Dr Waddell is a member of the Queensland Genomics Community Group where she contributes to a variety of projects in community engagement and the development of guidelines to enable the clinical use of genomics.
2014-current: QIMR Berghofer Medical Research Institute
2018-current: Coordinator of the Cancer Program
2016-current: Group Leader, Medical Genomics
2019-current: Adjunct Professor: QUT, Australia
2014-now: Adjunct Fellow: IMB, University of Queensland, Australia
2016-2018: Deputy Coordinator of the Genetics and Computational Biology Department
2015-2016: Team Head: Medical Genomics, QIMR Berghofer Medical Research Institute
2009-2014: Senior Post-doctoral Researcher, Institute for Molecular Bioscience, University of QLD, Australia
2005-2009: Post-doctoral Researcher, Queensland Institute of Medical Research, Brisbane Australia
2003-2005: Post-doctoral Researcher, Queensland Institute of Medical Research, Brisbane Australia
Dr Waddell’s research group focuses on the analysis of next generation sequence data to address clinical challenges in a variety of diseases.
The approaches taken include:
Ultimately, the aim is to take steps towards ‘personalised medicine’ to enable the diagnosis, management and treatment of patients.
2017: Inaugural QIMR Berghofer ACRF Prize for Cancer Research Excellence
2014: QIMR Berghofer Travel Award
2008: QIMR Berghofer Travel Award
2005: UICC International Cancer Technology Transfer Fellowship
2003: MRC PhD Scholarship & Special Training Fellowship in Bioinformatics
2000-2003: PhD (Thesis Title: Gene expression and breast cancer phenotype), University of Leicester, UK
1995-1999: BSc Hons (Biochemistry), University Surrey, UK